Difficulty: Medium
Average Score: 85%
Practice
The nursing class is studying monoclonal antibodies. What monoclonal antibody reacts to human T cells, disabling them and acting as an immune suppressor?
Correct answer
D
Rationale
The correct answer is D: Muromonab-CD3. This monoclonal antibody reacts to human T cells by binding to the CD3 receptor, which disables the T cells and acts as an immune suppressor. Muromonab-CD3 is specifically designed to target T cells and is used in conditions where T cell activity needs to be suppressed, such as in transplant rejection.
A: Adalimumab targets TNF-alpha and is used in autoimmune diseases like rheumatoid arthritis.
B: Cetuximab targets EGFR and is used in cancer treatment.
C: Rituximab targets CD20 on B cells and is used in conditions like lymphoma and rheumatoid arthritis.
Muromonab-CD3 is the correct answer because of its specific mechanism of action on T cells, distinguishing it from the other choices that target different cell types or pathways.
A: Adalimumab targets TNF-alpha and is used in autoimmune diseases like rheumatoid arthritis.
B: Cetuximab targets EGFR and is used in cancer treatment.
C: Rituximab targets CD20 on B cells and is used in conditions like lymphoma and rheumatoid arthritis.
Muromonab-CD3 is the correct answer because of its specific mechanism of action on T cells, distinguishing it from the other choices that target different cell types or pathways.